HRCT FEATURES OF COVID-19 IN RELATION TO DURATION OF DISEASE

Authors

  • Sajida Shah Department of Diagnostic Radiology Shifa International Hospital Islamabad
  • Zainab Malik Department of Diagnostic Radiology Shifa International Hospital Islamabad
  • Inamullah Shah Department of Surgery Fauji foundation Hospital, Rawalpindi
  • Sadia Babar Department of Diagnostic Radiology Shifa International Hospital Islamabad
  • Farhad Ahmad Department of Diagnostic Radiology Shifa International Hospital Islamabad
  • Arsalla Naveed Department of Diagnostic Radiology Shifa International Hospital Islamabad

Abstract

Background: Despite the fact that much has been written on various aspects of COVID-19, literature lacks a detailed and accurate description of HRCT findings in relation to the duration of the disease. The aim of this study was to investigate the difference in HRCT scan findings depending on the time after onset of the disease. The objective of the study is to identify and compare findings of HRCT scan at different time points after onset of the disease. Methods: A total of 224 patients, scanned over a period of 2 months, were placed in one of the four groups at the time of their scan depending on the days lapsed after their symptoms appeared. All scans were carried out on the same machine. Findings in each group were recorded and compared. A finding showing significant difference between groups indicates its importance in describing the course of the disease. Analysis was done on SPSS 23. Results: Ground glass opacities in posterior segments of one or more lobes was the most common feature and had a significant association with first 5 days of the disease (p=.027).  Interlobular thickening and subpleural reticulation, are found between 3­–5 days or later in the course of the disease (p=.000). Conclusion: Ground glass opacities located in posterior segments are the predominant feature in patients who are scanned up to 5 days after their symptoms appear. This feature is the most common in scans done in asymptomatic cases too. Interlobular septal thickening and subpleural reticulation start appearing at 3 days of disease process.

Author Biographies

Sajida Shah, Department of Diagnostic Radiology Shifa International Hospital Islamabad

Associate Consultant Radiology  

Zainab Malik, Department of Diagnostic Radiology Shifa International Hospital Islamabad

Resident Radiology  

Inamullah Shah, Department of Surgery Fauji foundation Hospital, Rawalpindi

Professor of Surgery  

Sadia Babar, Department of Diagnostic Radiology Shifa International Hospital Islamabad

Associate Consultant Radiology  

Farhad Ahmad, Department of Diagnostic Radiology Shifa International Hospital Islamabad

Resident Radiology  

Arsalla Naveed, Department of Diagnostic Radiology Shifa International Hospital Islamabad

Associate Consultant Radiology  

References

Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog 2020;16(5):e1008536.

Kuznetsova L. COVID-19: The World Community Expects the World Health Organization to Play a Stronger Leadership and Coordination Role in Pandemics Control. Front Public Health 2020;8:470.

CDC. 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel; Division of Viral Diseases, U.S. Centers for Disease Control and Prevention: Atlanta, GA, 2020.

Lv M, Wang M, Yang N, Luo X, Li W, Chen X, et al. Chest computed tomography for the diagnosis of patients with coronavirus disease 2019 (COVID-19): a rapid review and meta-analysis. Ann Transl Med 2020;8(10):622.

Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR Am J Roentgenol 2020;214(6):1280–6.

Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020;295(3):200463.

Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 2020;7(6):1012–23.

Adams HJA, Kwee TC, Yakar D, Hope MD, Kwee RM. Chest CT Imaging Signature of COVID-19 Infection: In Pursuit of the Scientific Evidence. Chest 2020;158(5):1885–95.

Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 2020;98(1):115094.

Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020;30(8):4381–9.

Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic management of patients with COVID-19: a systematic review. Infect Prevent Pract 2020;2(3):100061.

Zhang LP, Wang M, Wang Y, Zhu J, Zhang N. Focus on a 2019-novel coronavirus (SARS-CoV-2). Future Microbiol 2020;15(10):905–18.

Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, et al. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc 2020;95(7):1467–81.

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol 2020;215(1):87–93.

Sun Z, Zhang N, Li Y, Xu X. A systematic review of chest imaging findings in COVID-19. Quant Imaging Med Surg 2020;10(5):1058–79.

Sun Z, Zhang N, Li Y, Xu X. A systematic review of chest imaging findings in COVID-19. Quant Imaging Med Surg. 2020;10(5):1058–79. PMCID: PMC7242306.

Downloads

Published

2021-11-08